Clinical Trials Browser

Neoplasms × sargramostim × Dermatologic × Clear all

NCT00019890 2024-03-04

Vaccine Therapy in Treating Patients With High-Risk Stage III or Completely Resected Metastatic Melanoma

Phase 2 Completed

Melanoma, Neoplasms, Skin Neoplasms